New Biosynthetic System Shows Promise for Inflammatory Bowel Disease Treatment

Scientists have engineered a novel system combining ferritin nanozymes and a probiotic to target inflammatory bowel disease. This OFn-EcN system demonstrated effectiveness in preclinical models by neutralizing harmful gut compounds and restoring intestinal health. The findings suggest a potential new therapeutic approach for IBD.